Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case study.

Yang L, Wang K, Chen J, Jegga AG, Luo H, Shi L, Wan C, Guo X, Qin S, He G, Feng G, He L.

PLoS Comput Biol. 2011 Mar;7(3):e1002016. doi: 10.1371/journal.pcbi.1002016. Epub 2011 Mar 31.

2.

[Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].

G├╝zelcan Y, Scholte WF.

Tijdschr Psychiatr. 2006;48(4):295-302. Review. Dutch.

3.

The major histocompatibility complex region marked by HSP70-1 and HSP70-2 variants is associated with clozapine-induced agranulocytosis in two different ethnic groups.

Corzo D, Yunis JJ, Salazar M, Lieberman JA, Howard A, Awdeh Z, Alper CA, Yunis EJ.

Blood. 1995 Nov 15;86(10):3835-40.

4.

Clozapine-induced agranulocytosis and its genetic determinants.

Opgen-Rhein C, Dettling M.

Pharmacogenomics. 2008 Aug;9(8):1101-11. doi: 10.2217/14622416.9.8.1101. Review.

PMID:
18681784
6.

HSP70-2 9.0 kb variant is in linkage disequilibrium with the HLA-B and DRB1* alleles associated with clozapine-induced agranulocytosis.

Corzo D, Yunis JJ, Yunis EJ, Howard A, Lieberman JA.

J Clin Psychiatry. 1994 Sep;55 Suppl B:149-52. Review.

PMID:
7961560
7.

Harvesting candidate genes responsible for serious adverse drug reactions from a chemical-protein interactome.

Yang L, Chen J, He L.

PLoS Comput Biol. 2009 Jul;5(7):e1000441. doi: 10.1371/journal.pcbi.1000441. Epub 2009 Jul 24.

8.
9.

HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia.

Lieberman JA, Yunis J, Egea E, Canoso RT, Kane JM, Yunis EJ.

Arch Gen Psychiatry. 1990 Oct;47(10):945-8.

PMID:
2222133
10.

Blood dyscrasias in clozapine-treated patients in Italy.

Lambertenghi Deliliers G.

Haematologica. 2000 Mar;85(3):233-7.

11.

Testing the hypothesis that selenium deficiency is a risk factor for clozapine-induced agranulocytosis in rats.

Ip J, Uetrecht JP.

Chem Res Toxicol. 2008 Apr;21(4):874-8. doi: 10.1021/tx7004037. Epub 2008 Apr 2.

PMID:
18380444
12.

Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis.

Athanasiou MC, Dettling M, Cascorbi I, Mosyagin I, Salisbury BA, Pierz KA, Zou W, Whalen H, Malhotra AK, Lencz T, Gerson SL, Kane JM, Reed CR.

J Clin Psychiatry. 2011 Apr;72(4):458-63. doi: 10.4088/JCP.09m05527yel. Epub 2010 Sep 21.

PMID:
20868635
13.

[A case of neutropenia and agranulocytosis induced by clozapine. The importance of a drug surveillance program for their early detection].

Alfaro J, Berdichevsky E, Conte G, Tellez C.

Rev Med Chil. 1994 Jun;122(6):694-8. Spanish.

PMID:
7732216
14.

Clozapine: the commitment to patient safety.

Alphs LD, Anand R.

J Clin Psychiatry. 1999;60 Suppl 12:39-42. Review.

PMID:
10372610
15.

Clozapine and agranulocytosis: re-assessing the risks.

Drew L.

Australas Psychiatry. 2013 Aug;21(4):335-7. doi: 10.1177/1039856213491990. Epub 2013 Jun 26.

PMID:
23804114
16.

Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.

Atkin K, Kendall F, Gould D, Freeman H, Liberman J, O'Sullivan D.

Br J Psychiatry. 1996 Oct;169(4):483-8.

PMID:
8894200
18.

Drug-induced agranulocytosis: review of possible mechanisms, and prospects for clozapine studies.

Claas FH.

Psychopharmacology (Berl). 1989;99 Suppl:S113-7. Review.

PMID:
2682726
19.

Cost-effectiveness of clozapine monitoring after the first 6 months.

Zhang M, Owen RR, Pope SK, Smith GR.

Arch Gen Psychiatry. 1996 Oct;53(10):954-8.

PMID:
8857873
20.

Clozapine treatment after agranulocytosis induced by classic neuroleptics.

Bauer M, Mackert A.

J Clin Psychopharmacol. 1994 Feb;14(1):71-3.

PMID:
7908676
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk